Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021

SELL
$221.9 - $484.47 $830,793 - $1.81 Million
-3,744 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$129.91 - $234.98 $25,202 - $45,586
194 Added 5.46%
3,744 $880,000
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $387,589 - $660,229
3,550 New
3,550 $465,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.